EKF Diagnostics Holdings Plc (EKF):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:EKF Diagnostics Holdings Plc (EKF) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7112
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company that designs, develops, manufactures, and commercializes point-of-care (POC) devices and tests and chemical reagents used for manufacturing in central laboratories. Its POC range includes hemoglobin analyzers, glucose analyzers and HbA1c analyzers that can be used for screening, monitoring and diagnosing patients, and conducting tests for common infectious diseases and pregnancy, while its Central Laboratory range includes various clinical reagents and centrifuges. Its products find application in blood banks, general surgeries, pharmacies, hospitals, diabetes clinics, laboratories, and sports medicine. EKF Diagnostics offers its products across the world through its subsidiaries and distributors. The company operates manufacturing facilities in Russia, Poland, Germany, the UK, Ireland, and the US. EKF Diagnostics is headquartered in Cardiff, Wales, the UK.

EKF Diagnostics Holdings Plc (EKF) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
EKF Diagnostics Holdings Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
EKF Diagnostics Holdings Plc, Medical Equipment, Deal Details 12
Venture Financing 12
Selah Genomics Raises USD0.4 Million in Financing Round 12
Private Equity 13
Selah Genomics Acquires Lab21, Maker Of Nanotechnology-Enabled Products 13
Partnerships 14
Icahn School of Medicine Enters into Licensing Agreement with EKF Diagnostics 14
EKF Diagnostics Enters Into Licensing Agreement With Joslin Diabetes Center 15
Arcis Biotech Enters Into Licensing Agreement With EKF Diagnostics 16
EKF Diagnostics Enters into Distribution Agreement with Asahi Kasei Pharma 17
Ortho Clinical Diagnostics and EKF Diagnostic Enter into Agreement 18
Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 19
EKF Diagnostics Enters into Co-Development Agreement with Angle 20
EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 21
Selah Genomics Enters Into Licensing Agreement With UNIConnect For UniFlow 22
Equity Offering 23
EKF Diagnostics Raises USD7 Million in Private Placement of Shares 23
Asset Transactions 25
EKF Diagnostics Plans to Divest POC Dx Business for USD110 Million 25
Acquisition 26
EKF Diagnostics Sells Selah Genomics 26
Jin Jing to Acquire EKF Diagnostics 27
EKF Diagnostics Completes Acquisition Of Selah Genomics For US$75 Million 28
EKF Diagnostics To Acquire DiaSpect Medical For US$34.4 Million 29
EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For US$4 Million 30
EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 31
Selah Genomics Acquires EnGenCore, DNA Sequencing Company 33
EKF Diagnostics Acquires 3.62% Stake In Arcis Biotech For US$0.4 Million 34
EKF Diagnostics Sells International Brand Licensing For US$0.08 Million 35
EKF Diagnostics Holdings Plc – Key Competitors 36
EKF Diagnostics Holdings Plc – Key Employees 37
EKF Diagnostics Holdings Plc – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 40
Financial Announcements 40
Sep 19, 2018: EKF Diagnostics: Half yearly report 40
Mar 14, 2018: EKF Diagnostics Holdings: 2017 Final results 44
Sep 11, 2017: EKF Diagnostics Holdings: Half Yearly Report 48
Mar 20, 2017: EKF Diagnostics Holdings: Final results 49
Government and Public Interest 50
Jul 04, 2018: EKF Diagnostics: Exploring funding options for Renalytix AI business 50
Other Significant Developments 51
Jul 17, 2017: EKF publish new diabetes and HbA1c testing guide 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
EKF Diagnostics Holdings Plc, Medical Equipment, Key Facts, 2017 2
EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
EKF Diagnostics Holdings Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
EKF Diagnostics Holdings Plc, Deals By Market, 2012 to YTD 2018 9
EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Selah Genomics Raises USD0.4 Million in Financing Round 12
Selah Genomics Acquires Lab21, Maker Of Nanotechnology-Enabled Products 13
Icahn School of Medicine Enters into Licensing Agreement with EKF Diagnostics 14
EKF Diagnostics Enters Into Licensing Agreement With Joslin Diabetes Center 15
Arcis Biotech Enters Into Licensing Agreement With EKF Diagnostics 16
EKF Diagnostics Enters into Distribution Agreement with Asahi Kasei Pharma 17
Ortho Clinical Diagnostics and EKF Diagnostic Enter into Agreement 18
Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 19
EKF Diagnostics Enters into Co-Development Agreement with Angle 20
EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 21
Selah Genomics Enters Into Licensing Agreement With UNIConnect For UniFlow 22
EKF Diagnostics Raises USD7 Million in Private Placement of Shares 23
EKF Diagnostics Plans to Divest POC Dx Business for USD110 Million 25
EKF Diagnostics Sells Selah Genomics 26
Jin Jing to Acquire EKF Diagnostics 27
EKF Diagnostics Completes Acquisition Of Selah Genomics For US$75 Million 28
EKF Diagnostics To Acquire DiaSpect Medical For US$34.4 Million 29
EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For US$4 Million 30
EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 31
Selah Genomics Acquires EnGenCore, DNA Sequencing Company 33
EKF Diagnostics Acquires 3.62% Stake In Arcis Biotech For US$0.4 Million 34
EKF Diagnostics Sells International Brand Licensing For US$0.08 Million 35
EKF Diagnostics Holdings Plc, Key Competitors 36
EKF Diagnostics Holdings Plc, Key Employees 37
EKF Diagnostics Holdings Plc, Other Locations 38
EKF Diagnostics Holdings Plc, Subsidiaries 38

List of Figures
EKF Diagnostics Holdings Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
EKF Diagnostics Holdings Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
EKF Diagnostics Holdings Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[EKF Diagnostics Holdings Plc (EKF):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seagate Technology Public Limited Company:企業のM&A・事業提携・投資動向
    Seagate Technology Public Limited Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Seagate Technology Public Limited Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Sonoma Pharmaceuticals Inc (OCLS):企業の財務・戦略的SWOT分析
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • John Menzies Plc:企業の戦略・SWOT・財務分析
    John Menzies Plc - Strategy, SWOT and Corporate Finance Report Summary John Menzies Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Respiri Ltd (RSH):医療機器:M&Aディール及び事業提携情報
    Summary Respiri Ltd (Respiri), formerly iSonea Ltd, is a medical technology company that develops non-invasive medical devices and mobile health applications to improve the management of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The company’s prop …
  • Sumitomo Seika Chemicals Co Ltd (4008):企業の財務・戦略的SWOT分析
    Sumitomo Seika Chemicals Co Ltd (4008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Penn National Gaming Inc:企業のM&A・事業提携・投資動向
    Penn National Gaming Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Penn National Gaming Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Northam Platinum Limited:企業の戦略・SWOT・財務分析
    Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report Summary Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • vTv Therapeutics Inc (VTVT)-製薬・医療分野:企業M&A・提携分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc is a clinical stage pharmaceutical company that discovers, develops and commercializes small molecule drug candidates. The company’s pipeline products include azeliragon, TTP399, TTP273, HPP593, HPP737, HPP971 and hexokinase II inhibitors. I …
  • Icagen Inc:企業の戦略的SWOT分析
    Icagen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Belden Inc (BDC):企業の財務・戦略的SWOT分析
    Belden Inc (BDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Severn Trent Plc (SVT):企業の財務・戦略的SWOT分析
    Severn Trent Plc (SVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Alitalia – Societa Aerea Italiana S.p.A.:戦略・SWOT・企業財務分析
    Alitalia - Societa Aerea Italiana S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Alitalia - Societa Aerea Italiana S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • DEME NV:企業の戦略的SWOT分析
    DEME NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Isrotel Hotels Management Inc.
    Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Frontline Ltd (FRO):企業の財務・戦略的SWOT分析
    Frontline Ltd (FRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Noble Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noble Life Sciences Inc (Noble Life Sciences) is a contract research organization that offers vaccines, drugs, and medical device development services. The company provides preclinical services such as disease and animal models, drug pharmacology and exploratory toxicology, analytical and la …
  • Greif, Inc. (GEF):企業の財務・戦略的SWOT分析
    Greif, Inc. (GEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Benesse Holdings Inc (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings Inc (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sigla, S.A.:企業の戦略的SWOT分析
    Sigla, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Easywell Biomedical Inc (1799):医療機器:M&Aディール及び事業提携情報
    Summary Easywell Biomedical Inc (Easywell), formerly Actherm Inc is a supplier of medical devices, pharmaceuticals and regenerative medicines. The company’s medical devices comprise pain and systems, non-contact, forehead infrared thermometer, infrared ear thermometer and digital clinical thermomete …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆